Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Stifel Maintains Buy on Charah Solns, Adjusts Price Target to $17 - 1-for-10 Reverse Stock Split

Author: Benzinga Newsdesk | December 30, 2022 09:07am

Stifel analyst Michael Hoffman maintains Charah Solns (NYSE:CHRA) with a Buy, adjusts price target to $17 - 1-for-10 reverse stock split.

Posted In: CHRA